A majority of patients with chronic viral hepatitis develop anemia. It is important to know the type of anemia a patient has because treatment varies depending on the type of anemia.
In this blog post, we will discuss how to diagnose and treat hemolytic anemia in CVID patients. The most common cause for hemolytic anemia that occurs in people with chronic viral hepatitis is autoimmune hemolysis. This means the body’s immune system mistakenly starts attacking red blood cells as if they were foreign invaders like bacteria or viruses. People who have autoimmune hematological disorders such as primary immunodeficiency (PID) are at risk for developing autoantibodies which can attack their own red blood cells.
Hemolytic anemia in CVID patients may also be caused by infiltrates of the bone marrow or spleen with a virus or bacteria, which can then lead to decreased production of new RBCs. Treatments for hemolysis in people with chronic viral hepatitis include transfusion therapy and treatment specific for autoimmune hematological disorders such as PID (e.g., corticosteroids).
Continue writing next sentences: For most clients with CVID who develop which type of anemia, autoantibodies are responsible for destroying their red blood cells due to immune system abnormalities occurring from either another underlying disorder like primary immunodeficiency disease (PID).